Developing a polymer-based bioresorbable scaffold (BRS) – or stent .

Arterius Ltd is engaged in the development of an innovative polymer-based bioresorbable scaffold (BRS), more commonly known as a ‘stent’. The bioresorbable attribute aims to allow the stent to dissolve over time, before being absorbed by the body. Therefore, this will mean that there is no requirement to physically remove the stent. We believe that the Company’s solution offers an opportunity to minimise the frequency of surgery or medical interventions and could give patients a better post-operative quality of life.

  • Product

    Life Sciences EIS
  • Sector

  • Status

  • HMRC

    Advanced Assurance